Title |
Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease
|
---|---|
Published in |
Cochrane database of systematic reviews, July 2014
|
DOI | 10.1002/14651858.cd005055.pub3 |
Pubmed ID | |
Authors |
Matthew Bizzarro, Ian Gross, Fabiano T Barbosa |
Abstract |
Nitric oxide (NO) is a prevalent molecule in humans that is responsible for many physiologic activities including pulmonary vasodilation. An exogenous, inhaled form (iNO) exists that mimics this action without affecting systemic blood pressure. This therapy has been implemented in the treatment of pulmonary hypertension. This review examines the efficacy of iNO in the postoperative management of infants and children with congenital heart disease (CHD). The original review was published in 2005, updated in 2008 and again in 2014. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 186 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 2% |
Unknown | 183 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 21 | 11% |
Student > Master | 18 | 10% |
Student > Bachelor | 18 | 10% |
Student > Postgraduate | 17 | 9% |
Other | 14 | 8% |
Other | 38 | 20% |
Unknown | 60 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 62 | 33% |
Nursing and Health Professions | 21 | 11% |
Social Sciences | 7 | 4% |
Psychology | 4 | 2% |
Unspecified | 4 | 2% |
Other | 16 | 9% |
Unknown | 72 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 July 2019.
All research outputs
#15,982,712
of 25,728,855 outputs
Outputs from Cochrane database of systematic reviews
#11,110
of 13,136 outputs
Outputs of similar age
#129,448
of 242,974 outputs
Outputs of similar age from Cochrane database of systematic reviews
#196
of 231 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,136 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one is in the 14th percentile – i.e., 14% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,974 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 231 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.